Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2026-02-20 @ 6:06 PM
Study NCT ID:
NCT00521261
Status:
WITHDRAWN
Last Update Posted:
2014-03-05
First Post:
2007-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10
Start Date Type:
None
Primary Completion Date:
2008-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-24
First Submit QC Date:
None
Study First Post Date:
2007-08-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-03-04
Last Update Post Date:
2014-03-05
Last Update Post Date Type:
ESTIMATED